GEN

Bio-Matrix Scientific Decides to Develop Validation and Protocol Process

Protocols will form key part of company’s quality system. Bio-Matrix Scientific Group is entering the facility validation process arena. Working with company’s chief scientific advisor, Geoffrey ...
NBC News

Bio-Matrix Scientific Group Chairman Sees Future of Stem Cell Therapies Focused on Stem Cell Repositories

SAN DIEGO, Sept. 30, 2010 (GLOBE NEWSWIRE) -- Bio-Matrix Scientific Group Inc. (OTCBB:BMSN) Chairman & CEO David Koos commented today about the future of stem cell therapy and how advances in ...
Business Wire

Bio-Matrix Scientific Group Finalizing Patent Applications for Three New Devices

SAN DIEGO--(BUSINESS WIRE)--April 20, 2005--Bio-Matrix Scientific Group Inc. (Pink Sheets:BMXG) announced today that it is preparing to file three new patent applications. These patent applications ...
Business Wire

Bio-Matrix Scientific CEO Highlights Plans for First Commercial Adult Stem Cell Bank Derived from Fat and Medical Devices Aimed at Plastic Surgeons and Liposuction Patients

SAN DIEGO--(BUSINESS WIRE)--Bio-Matrix Scientific Group (OTCBB:BMSN) Chairman and CEO David R. Koos gives his views about rolling out a new direction in stem cell banking by providing the first ...
Purdue University

Matrix-Bio signs metabolomics biomarker licensing agreement with Quest Diagnostics for development of breast cancer recurrence test

FORT WAYNE and WEST LAFAYETTE, Ind. - Matrix-Bio Inc., a diagnostics company that uses metabolite profiling to detect cancer and other diseases, has signed an exclusive global licensing and marketing ...